Brucellosis

Journal of the American Veterinary Medical Association

Volumn 233, Issue 6, 2008, Pages 900-908

  Glynn, M Kathleen ^a   Lynn, Tracey V ^b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR EPIDEMIOLOGY AND ANIMAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; BIOLOGICAL WARFARE; BRUCELLA; BRUCELLOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; HUMAN; ISOLATION AND PURIFICATION; PATHOLOGY; PROGNOSIS; PUBLIC HEALTH; REVIEW; TREATMENT OUTCOME; UNITED STATES; ZOONOSIS;

ANIMALS; BIOTERRORISM; BRUCELLA; BRUCELLOSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PROGNOSIS; PUBLIC HEALTH; TREATMENT OUTCOME; UNITED STATES; ZOONOSES;

EID: 53049086531     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.233.6.900     Document Type: Review

References (107)

1. Cosgrove SE, Perl TM, Song X, et al. Ability of physicians to diagnose and manage illness due to category A bioterrorism agents. Arch Intern Med 2005;165:2002-2006.
2. Pappas G, Papadimitriou P, Akritidis N, et al. The new global map of human brucellosis. Lancet Infect Dis 2006;6:91-99.
3. Capasso L. Bacteria in two-millennia-old cheese, and related epizoonoses in Roman populations. J Infect 2002;45:122-127.
4. Evans AC. Brucellosis in the United States. Am J Public Health 1947;37:139-151.
5. Verger JM, Grimont F, Grimont PAD, et al. Taxonomy of the genus Brucella. Ann Inst Pasteur Microbiol 1987;138:235-238.
6. Hailing SM, Peterson-Burch BD, Bricker BJ, et al. Completion of the genome sequence of Brucella abortus and comparison of the highly similar genomes of Brucella melitensis and Brucella suis. J Bacteriol 2005;187:2715-2726.
7. Chain PSG, Comerci DJ, Tolmasky ME, et al. Whole-genome analyses of speciation events in pathogenic brucellae. Infect Immun 2005;73:8353-8361.
8. Osterman B, Moriyon I. International Committee on Systematics of Prokaryotes: Subcommittee on the taxonomy of Brucella. Int J Syst Evol Microbiol 2006;56:1173-1175.
9. Cloeckaert A, Verger JM, Grayon M, et al. Classification of Brucella spp. isolated from marine mammals by DNA polymorphism at the omp2 locus. Microbes Infect 2001;3:729-738.
10. Foster G, Osterman BS, Godfroid J, et al. Brucella ceti sp. nov. and Brucella pinnipedialis sp. nov. for Brucella strains with cetaceans and seals as their preferred hosts. Int J Syst Evol Microbiol 2007;57:2688-2693.
11. De BK, Stauffer L, Koylass MS, et al. Novel Brucella strain (BO1) associated with a prosthetic breast implant infection. J Clin Microbiol 2008;46:43-49.
12. Scholz HC, Hubalek A, Sedlacek I, et al. Brucella microti sp. nov., isolated from the common vole Microtus arvalis. Int J Syst Evol Microbiol 2008;58:375-382.
13. Tessaro SV, Forbes LB. Brucella suis biotype 4: a case of granulomatous nephritis in a barren ground caribou (Rangifer tarandus groenlandicus L.) with a review of the distribution of rangiferine brucellosis in Canada. J Wildl Dis 1986;22:479-483.
14. Vitovec J, Vladik P, Zahor Z, et al. Morphological study of 70 cases of brucellosis in rabbits caused by Brucella suis. Vet Med (Praha) 1976;21:359-368.
15. Ewalt DR, Payeur JB, Rhyan JC, et al. Brucella suis biovar 1 in naturally infected cattle: a bacteriological, serological, and histological study. J Vet Diagn Invest 1997;9:417-420.
16. Kahler SC. Brucella melitensis infection discovered in cattle for first time, goats also infected. J Am Vet Med Assoc 2000;216:648.
17. Refai M. Incidence and control of brucellosis in the Near East region. Vet Microbiol 2002;90:81-110.
18. Ko J, Splitter GA. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev 2003;16:65-78.
19. Paulsen IT, Seshadri R, Nelson KE, et al. The Brucella suis genome reveals fundamental similarities between animal and plant pathogens ans symbionts. Proc Natl Acad Sci U S A 2002;99:13148-13153.
20. Whatmore AM, Perrett LL, MacMillan AP. Characterisation of the genetic diversity of Brucella by multilocus sequencing. BMC Microbiol [serial online]. 2007;7:34. Available at: www.biomed-central.com/1471-2180/7/34. Accessed Month Day, Year.
21. Le Fleche P, Jacques I, Grayon M, et al. Evaluation and selection of tandem repeat loci for a Brucella MLVA typing assay. BMC Microbiol [serial online]. 2006;6:9. Available at: www.biomedcentral.com/1471-2180/6/9. Accessed Month Day, Year.
22. CDC. Laboratory-acquired brucellosis - Indiana and Minnesota, 2006. MMWR Morb Mortal Wkly Rep 2008;57:39-42.
23. Alexander B, Schnurrenberger PR, Brown RR. Numbers of Brucella abortus in the placenta, umbilicus and fetal fluid of two naturally infected cows. Vet Rec 1981;108:500.
24. Pappas G, Panagopoulou P, Christou L, et al. Brucella as a biological weapon. Cell Mol Life Sci 2006;63:2229-2236.
25. Chheda S, Lopez SM, Sanderson EP. Congenital brucellosis in a premature infant. Pediatr Infect Dis J 1997;16:81-83.
26. Giannacopoulos I, Eliopoulou MI, Ziambaras T, et al. Transplacentally transmitted congenital brucellosis due to Brucella abortus. J Infect 2002;45:209-210.
27. Poulou A, Markou F, Xipolitos I, et al. A rare case of Brucella melitensis infection in an obstetrician during the delivery of a transplacentally infected infant. J Infect 2006;53:e39-e41.
28. Ruben B, Band JD, Wong P, et al. Person-to-person transmission of Brucella melitensis. Lancet 1991;337:14-15.
29. Kotton CN. Zoonoses in solid-organ and hematopoietic stem cell transplant recipients. Clin Infect Dis 2007;44:857-866.
30. Ashford DA, di Pietra J, Lingappa J, et al. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine 2004;22:3435-3439.
31. Berkelman RL. Human illness associated with use of veterinary vaccines. Clin Infect Dis 2003;37:407-414.
32. Sewell DL. Laboratory-associated infections and biosafety. Clin Microbiol Rev 1995;8:389-405.
33. Miller CD, Songer JR, Sullivan JF. A twenty-five year review of laboratory-acquired human infections at the National Animal Disease Center. Am Ind Hyg Assoc J 1987;48:271-275.
34. Yagupsky P, Baron EJ. Laboratory exposures to brucellae and implications for bioterrorism. Emerg Infect Dis 2005;11:1180-1185.
35. Demirdal T, Demirturk N. Laboratory-acquired brucellosis. Ann Acad Med Singapore 2008;37:86-87.
36. Waring SC. Brucellosis. In: Kahn CM, Line S, eds. Merck veterinary manual. 9th ed. Whitehouse Station, NJ: Merck, 2005;2546.
37. Public Health Agency of Canada Office of Laboratory Security. Material safety data sheet - infectious substances, Brucella spp. Available at: www.phac-aspc.gc.ca/msds-ftss/msds23e.html. Accessed Mar 5, 2008.
38. Ragan VE. The Animal and Plant Health Inspection Service (APHIS) brucellosis eradication program in the United States. Vet Microbiol 2002;90:11-18.
39. USDA, APHIS. Brucellosis eradication: uniform methods and rules. Washington, DC: UDSA, APHIS, 2003. Available at: www.aphis.usda.gov/ animal_health/animal_diseases/brucellosis/downloads/umr_bovine_bruc.pdf. Accessed Aug 25, 2007.
40. Donch DA, Gertonson AA, Rhyan JC, et al. Status report - fiscal year 2006. Cooperative State-Federal Brucellosis Eradication Program. Washington, DC: USDA, APHIS, 2007. Available at: www.aphis.usda.gov/animal_health/ animal_diseases/brucellosis/downloads/yearly_rpt.pdf. Accessed Aug 25, 2007.
41. Wise RI. Brucellosis in the United States. Past, present, and future. JAMA 1980;244:2318-2322.
42. Buchanan TM, Hendricks SL, Patton CM, et al. Brucellosis in the United States, 1960-1972; an abattoir-associated disease. Part III. Epidemiology and evidence for acquired immunity. Medicine (Baltimore) 1974;53:427-439.
43. Meyer ME, Meagher M. Brucellosis in free-ranging bison (Bison bison) in Yellowstone, Grand Teton, and Wood Buffalo National Parks: a review. J Wildl Dis 1995;31:579-598.
44. Etter RP, Drew ML. Brucellosis in elk of eastern Idaho. J Wildl Dis 2006;42:271-278.
45. Gresham CS, Gresham CA, Duffy MJ, et al. Increased prevalence of Brucella suis and pseudorabies virus antibodies in adults of an isolated feral swine population in coastal South Carolina. J Wildl Dis 2002;38:653-656.
46. Stoffregen WC, Olsen SC, Jack WC, et al. Diagnostic characterization of a feral swine herd enzootically infected with Brucella. J Vet Diagn Invest 2007;19:227-237.
47. Chan J, Baxter C, Wenman WM. Brucellosis in an Inuit child, probably related to caribou meat consumption. Scand J Infect Dis 1989;21:337-338.
48. Luna-Martinez JE, Mejia-Teran C. Brucellosis in Mexico: current status and trends. Vet Microbiol 2002;90:19-30.
49. Wanke MM. Canine brucellosis. Anim Reprod Sci 2004;82-83:195-207.
50. Hollett RB. Canine brucellosis: outbreaks and compliance. Theriogenology 2006;66:575-587.
51. Brower A, Okwumabua O, Massengill C, et al. Investigation of the spread of Brucella canis via the US interstate dog trade. Int J Infect Dis 2007;11:454-458.
52. Scheftel J. Brucella canis: potential for zoonotic transmission. Compend Contin Educ Pract Vet 2003;25:846-853.
53. Piampiano P, McLeary M, Young LW, et al. Brucellosis: unusual presentations in two adolescent boys. Pediatr Radiol 2000;30:355-357.
54. Ying W, Nguyen MQ, Jahre JA. Brucella canis endocarditis: case report. Clin Infect Dis 1999;29:1593-1594.
55. Lewis GE Jr, Anderson JK. The incidence of Brucella canis antibodies in sera of military recruits. Am J Public Health 1973;63:204-205.
56. Monroe PW, Silberg SL, Morgan PM, et al. Seroepidemiological investigation of Brucella canis antibodies in different human population groups. J Clin Microbiol 1975;2:382-386.
57. Polt SS, Dismukes WE, Flint A, et al. Human brucellosis caused by Brucella canis: clinical features and immune response. Ann Intern Med 1982;97:717-719.
58. Groussaud P, Shankster SJ, Whatmore AM. Molecular typing divides marine mammal strains of Brucella into at least three groups with distinct host preferences. J Med Microbiol 2007;56:1512-1518.
59. Sohn AH, Probert WS, Glaser CA, et al. Human neurobrucellosis with intracerebral granuloma caused by a marine mammal Brucella spp. Emerg Infect Dis 2003;9:485-488.
60. McDonald WL, Jamaludin R, Mackereth G, et al. Characterization of a Brucella sp. strain as a marine-mammal type despite isolation from a patient with spinal osteomyelitis in New Zealand. J Clin Microbiol 2006;44:4363-4370.
61. Brew SD, Perrett LL, Stack JA, et al. Human exposure to Brucella recovered from a sea mammal. Vet Rec 1999;144:483.
62. Wharton M, Chorba TL, Vogt RL, et al. Case definitions for public health surveillance. MMWR Recomm Rep 1990;39:1-43.
63. CDC. Summary of notifiable diseases - United States, 2006. MMWR Morb Mortal Wkly Rep 2008;55:1-94.
64. Doyle TJ, Bryan RT. Infectious disease morbidity in the US region bordering Mexico, 1990-1998. J Infect Dis 2000;182:1503-1510.
65. Chomel BB, DeBess EE, Mangiamele DM, et al. Changing trends in the epidemiology of human brucellosis in California from 1973 to 1992: a shift toward foodborne transmission. J Infect Dis 1994;170:1216-1223.
66. Taylor JP, Perdue JN. The changing epidemiology of human brucellosis in Texas, 1977-1986. Am J Epidemiol 1989;130:160-165.
67. Fosgate GT, Carpenter TE, Chomel BB, et al. Time-space clustering of human brucellosis, California, 1973-1992. Emerg Infect Dis 2002;8:672-678.
68. Troy SB, Rickman LS, Davis CE. Brucellosis in San Diego: epidemiology and species-related differences in acute clinical presentations. Medicine (Baltimore) 2005;84:174-187.
69. Aronson NE, Sanders JW, Moran KA. In harm's way: infections in deployed American military forces. Clin Infect Dis 2006;43:1045-1051.
70. Memish ZA, Balkhy HH. Brucellosis and international travel. J Travel Med 2004;11:49-55.
71. Adams LG. The pathology of brucellosis reflects the outcome of the battle between the host genome and the Brucella genome. Vet Microbiol 2002;90:553-561.
72. Gorvel JP, Moreno E. Brucella intracellular life: from invasion to intracellular replication. Vet Microbiol 2002;90:281-297.
73. Young EJ. An overview of human brucellosis. Clin Infect Dis 1995;21:283-289.
74. Bulgin MS. Epididymitis in rams and lambs. Vet Clin North Am Food Anim Pract 1990;6:683-690.
75. Khan MY, Mah MW, Memish ZA. Brucellosis in pregnant women. Clin Infect Dis 2001;32:1172-1177.
76. Peery TM, Belter LF. Brucellosis and heart disease. II. Fatal brucellosis: a review of the literature and report of new cases. Am J Pathol 1960;36:673-697.
77. Jeroudi MO, Halim MA, Harder EJ, et al. Brucella endocarditis. Br Heart J 1987;58:279-283.
78. Al Dahouk S, Tomaso H, Nockler K, et al. Laboratory-based diagnosis of brucellosis - a review of the literature. Part II: serological tests for brucellosis. Clin Lab 2003;49:577-589.
79. Araj GF, Kattar MM, Fattouh LG, et al. Evaluation of the PANBIO Brucella Immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays for diagnosis of human brucellosis. Clin Diagn Lab Immunol 2005;12:1334-1335.
80. Delpino MV, Fossati CA, Baldi PC. Occurrence and potential diagnostic applications of serological cross-reactivities between Brucella and other alpha-proteobacteria. Clin Diagn Lab Immunol 2004;11:868-873.
81. Lucero NE, Escobar GI, Ayala SM, et al. Diagnosis of human brucellosis caused by Brucella canis. J Med Microbiol 2005;54:457-461.
82. Polt SS, Schaefer J. A microagglutination test for human Brucella canis antibodies. Am J Clin Pathol 1982;77:740-744.
83. Wallach JC, Giambartolomei GH, Baldi PC, et al. Human infection with M- strain of Brucella canis. Emerg Infect Dis 2004;10:146-148.
84. Brucellosis. Title 9 CFR part 78. Available at: ecfr.gpoaccess.gov/cgi/t/ text/text-idx?c=ecfr&sid=da18cb9a55ac9f50e45ca30510c8cb64&rgn= div5&view=text&node=9:1.0.1.3.23&idno=9. Accessed Nov 23, 2007.
85. Bricker BJ. Diagnostic strategies used for the identification of Brucella. Vet Microbiol 2002;90:433-434.
86. Lucero NE, Escobar GI, Ayala SM, et al. Sensitivity and specificity of an indirect enzyme-linked immunoassay for the diagnosis of Brucella canis infection in dogs. J Med Microbiol 2002;51:656-660.
87. Ebani VV, Cerri D, Fratini F, et al. Serological diagnosis of brucellosis caused by Brucella canis. New Microbiol 2003;26:65-73.
88. Kim JW, Lee YJ, Han MY, et al. Evaluation of immunochromatographic assay for serodiagnosis of Brucella canis. J Vet Med Sci 2007;69:1103-1107.
89. Carmichael LE, Shin SJ. Canine brucellosis: a diagnostician's dilemma. Semin Vet Med Surg (Small Anim) 1996;11:161-165.
90. Pappas G, Akritidis N, Tsianos E. Effective treatments in the management of brucellosis. Expert Opin Pharmacother 2005;6:201-209.
91. Pappas G, Papadimitriou P, Christou L, et al. Future trends in human brucellosis treatment. Expert Opin Investig Drugs 2006;15:1141-1149.
92. Pappas G, Siozopoulou V, Akritidis N, et al. Doxycycline-rifampicin: physicians' inferior choice in brucellosis or how convenience reigns over science. J Infect 2007;54:459-462.
93. Ariza J, Bosilkovski M, Cascio A, et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med 2007;4:e317.
94. Jacobs F, Abramowicz D, Vereerstraeten P, et al. Brucella endocarditis: the role of combined medical and surgical treatment. Rev Infect Dis 1990;12:740-744.
95. Wanke MM, Delpino MV, Baldi PC. Use of enrofloxacin in the treatment of canine brucellosis in a dog kennel (clinical trial). Theriogenology 2006;66:1573-1578.
96. Christopher GW, Agan MB, Cieslak TJ, et al. History of US military contributions to the study of bacterial zoonoses. Mil Med 2005;170:39-48.
97. Rotz LD, Khan AS, Lillibridge SR, et al. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002;8:225-230.
98. CDC, Office of Inspector General, Department of Health and Human Services. Possession, use, and transfer of select agents and toxins. Final rule. Fed Regist 2005;70:13293-13325.
99. APHIS. Agricultural bioterrorism protection act of 2002; Possession, use, and transfer of biological agents and toxins; final rule. Fed Regist 2005;70:13241-13292.
100. Blasco JM. Existing and future vaccines against brucellosis in small ruminants. Small Ruminant Res 2006;62:32-37.
101. Banai M. Control of small ruminant brucellosis by use of Brucella melitensis Rev.1 vaccine: laboratory aspects and field observations. Vet Microbiol 2002;90:497-519.
102. Bardenstein S, Mandelboim M, Ficht TA, et al. Identification of the Brucella melitensis vaccine strain Rev.1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene. J Clin Microbiol 2002;40:1475-1480.
103. Olsen SC, Stoffregen WS. Essential role of vaccines in brucellosis control and eradication programs for livestock. Expert Rev Vaccines 2005;4:915-928.
104. Olsen SC, Fach SJ, Palmer MV, et al. Immune responses of elk to initial and booster vaccinations with Brucella abortus strain RB51 or 19. Clin Vaccine Immunol 2006;13:1098-1103.
105. Greater Yellowstone Interagency Brucellosis Committee. Wildlife and brucellosis in the Greater Yellowstone Area - an education guide for hunters. USDA, APHIS. Available at: fwp.mt.gov/fwppaperapps/hunting/brucellosis.pdf. Accessed Aug 27, 2007.
106. US Department of Health and Human Services, CDC, National Institutes of Health. Biosafety in microbiological and biomedical laboratories (BMBL). 5th ed. Washington, DC: US Government Printing Office, 2007. Available at: www.cdc.gov/OD/OHS/biosfty/bmbl5/bmbl5toc.htm. Accessed Aug 17, 2007.
107. CDC. Update: potential exposures to attenuated vaccine strain Brucella abortus RB51 during a laboratory proficiency test - United States and Canada, 2007. MMWR Morb Mortal Wkly Rep 2008;57:36-39.